Advertisement
Advertisement
U.S. Markets close in 10 mins
Advertisement
Advertisement
Advertisement
Advertisement

Northwest Biotherapeutics, Inc. (NWBO)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
0.6299+0.0069 (+1.11%)
As of 03:34PM EDT. Market open.
Advertisement

Yahoo Finance will soon be upgrading our Conversations message board platform to provide a better experience for our users. Only comments published since April 21, 2021 will be visible on Yahoo Finance after the upgrade. If you wish to download and save any of your older comments, please submit a request via the Privacy Dashboard by no later than Aug. 15, 2022.

Sign in to post a message.
  • V
    Vic Ferrari
    Most inside & outside short sellers are long gone working this generational scam down from 100 pps 20 years ago enjoying multiple R/S along the way.

    All are waiting for the next 15 or 20 R/S so they can put their great grandchildren through college.
  • M
    Marco
    Back by popular demand for the 9th consecutive week. The NWBO… Opps! They did it again tour.

    Northwest Biotherapeutics disclosed that their cancer vaccine DCVax-L performed worse than placebo when given to patients with newly diagnosed glioblastoma. In the phase III trial, 232 patients were treated with DCVax-L and 99 received placebo; patients who received DCVax-L had a 10% increased risk of tumor progression compared with those who received the placebo. In addition, those who received the vaccine experienced tumor recurrence after a median of 6.2 months compared with 7.6 months in those in the control group.
  • P
    Phil
    Is a 26 year old company with no commercialized product still considered a bio startup? Only non pumper reply’s please.
  • P
    Phil
    Linda F. Ponzi working a another masterpiece once again today. Watch the daily volume. When volume spikes the equity drops in pps. Means that the upward tape is being painted to deceive retail buyers. While insiders convert and dump .25 cent warrants and .01 options.
  • k
    krerik
    There has to be a reason Linda is not having an Annual Stockholders Meeting but the fact she isn't sharing it means it is not good. No wonder institutional investors washed their hands of NWBO long ago.
  • R
    Ronnie
    The only one not out of money is Linda F. Ponzi and her insider cabal personal heist.

    The facts are… Book Value Per Share (mrq) -0.12
    Cash Flow Statement
    Operating Cash Flow (ttm) -38.02M
    Levered Free Cash Flow (ttm) -268.79M

    No institutional or insider interest when this equity was 100 pps, 50 pps , 25 pps , under a buck then the first reverse split ,then after the second reverse split, now after the third inevitable one soon at 67 pennies or below. Some people choose to be victims of history, other students…. Wash, rinse, repeat… They know, when will you? Equity down from 100 pps at inception before multiple reverse splits. Just in 2020 trading at 2.40 pps. Free float approaching 1 billion shares. Then…
    July 2022 says… Many institutions and funds such as Blackrock, Vanguard, Statestreet etc. have microcar divisions and even invest in companies less than 1 pps. They can spot this scam a mile away.
    https://www.nasdaq.com/market-activity/stocks/nwbo/institutional-holdings
    Interesting 18 full time employees and not one has bought a single share on the open market. Not even Linda F.. Ponz”s is chauffeur.
    https://www.nasdaq.com/market-activity/stocks/nwbo/insider-activity
    Less
  • J
    James
    The company is not only in violation of its own bylaws, but also both Delaware law as well when it comes to the ASM (at least 16 months since the last). The SEC can be fairly responsive on some issues, while seemingly ignoring others. I've no idea how they would react, but I suspect it's worth a few minutes of your time to do something constructive about it.
  • L
    LearningCurve2020
    Hubber asked the wife for more cash to average down with "Special C's".
  • J
    Jill
    60 penny wall still holding..
  • B
    Bobby
    $NWBO has offered the lamest and most all-encompassing “Covid ate my clinical trial results” excuse in biotech history.

    This is so awful good, it should be taught in business schools.

    From the new 10-Q:
  • L
    LearningCurve2020
    In my many years of biotech investing I have never encountered a public company where the CEO/CFO/COB personally owned not one but two private CDMO's made possible by that public company. It's incredible.
  • L
    LearningCurve2020
    I personally think it was very disingenuous that doctors or the company never addressed the screening halt and instead tried to confuse the situation by addressing a much older trial halt for financial reasons which everyone already knew about.

    https://www.reuters.com/article/us-northwest-bio-suspension/northwest-bio-suspends-patient-screening-in-brain-cancer-trial-idUKKCN0QQ1UC20150821
  • V
    Vic Ferrari
    Float has been increasing exponentially since 2915 ever since Hemphill departed. Someone in dumping shares under the SEC filing requirements, who else better than a non company employee family member. Strangely the CEO voluntarily removes NWBO off the NASDAO benefiting from lack Pink Sheet filing requirements. Hemphills trades will open a huge can of worms.
  • L
    LearningCurve2020
    Looks like the Hubbers helping to get her to the airport.
  • k
    krerik
    Wow, here we have a peer-reviewed article by another Chinese brain surgeon that just might be way ahead in the fight against GBM. All the resources and time being wasted on DCVax-L can now be redirected...
    https://www.science.org/doi/10.1126/scitranslmed.abn1128
  • P
    P
    DCVax-L will be the new standard of care for GBM. Statistically significant survival for nGBM and rGBM.
    DCVax-L more than doubled the 5-yr survival. Excellent safety profile. Easily used in combination.

    The DCVax platform is applicable to any solid tumor. The addressable market is enormous. The chemo poison companies will be displaced.

    The paid bashers on this board have dedicated significant time to misrepresenting the trial results. Why?
  • L
    LongSlayer
    Market ripped (again). NWBO slipped (again). Wasn’t this baby supposed to “moon” on May 10th after the “presentation” at NYAS? Anyone want to explain what happened? Pain, desperation, and despair ahead for all longs.
    Bearish
  • P
    Paul
    Do we get into the .50's today? It's NWBO Friday. What BS will they be saying in iHub land? Don't go against their narrative or you will be labeled a "short". It's like a cult, kind of scary, but entertaining at the same time.
  • P
    Phil
    No wonder the CEO and cronies never take questions or have interactive conference calls. They don’t even appear for photo ops. Their FB, Twitter Feeds are last active in 2015. Don’t even think they know what Instagram is? Who is in charge of IR? How do investors get information or ask questions or the patient community interact.

    Why is all communication orchestrated through company shills in chat rooms.
  • J
    Jill
    Danishboob is just a pimp. Pumping CVM from the mid- twenties pps in April of 21 to the 3,s as of today.

    John Carroll, a Pulitzer-Prize winner (UPDATE: Carroll writes to note that he was part of a team that won the Pulitzer) who is editor in chief of the life-sciences group at DC-based FierceMarkets, wrote this on Twitter, : “Touting ‘case studies’ about cancer drugs is grossly unethical. Pandering to a market of dying patients. The stuff of snake oil sales.”

    When you mysteriously began posting on the NWBO thread 1 year plus ago NWBO was over 2.00 pps. Don’t tell me you are part of the criminal cabal helping Ponzi dump .01 cent options and convert .25 penny warrants. Feel free to have Matt or MichaelK or Krangler or Garton Reply…
Advertisement
Advertisement